Lunatus Healthcare

Home
United Arab Emirates
Dubai
Lunatus Healthcare

Lunatus | The Leading Full-Service Healthcare Partner in The Middle East.

Lunatus Healthcare is a leading full-service healthcare partner in the Middle East, specializing in turnkey solutions that drive brand success across the Arabian Gulf and Middle East region. Since 2003, we’ve been committed to providing comprehensive representation through our core solutions:

- Regulatory
- Sales
- Marketing
- Distribution
- Supply Chain Management
- Pharmacovigilance

Headquartered in Dubai with branches across the Middle East, we support a diverse portfolio of over 40 global partners and 300+ product lines, spanning pharmaceuticals, healthcare, OTC, consumer health, and medical equipment. Our approach ensures every stage—from market entry to brand development—is handled seamlessly, establishing profitable and sustainable brand presence. Lunatus is proud to serve various therapeutic areas including:

- Cardiovascular
- Dermatology
- ENT
- Gastroenterology
- Gynecology
- Infectious Diseases
- Internal Medicine
- Neurology
- Oncology
- Ophthalmology
- Orthopedics
- Pain Management
- Pediatrics
- Psychiatry
- Vascular
- Weight Loss

At Lunatus, we strive to set the standard for excellence in healthcare, marketing, and business across the region, delivering innovative solutions that make us the preferred partner for global healthcare brands.

09/12/2025

We had the pleasure of hosting an interactive local Xeomin® workshop in RAK on November 28th, 2025, at Ibrahim Bin Hamad Obaidullah Hospital, UAE.
Led by Dr. Mahesh Cirasanambati, the hands-on program brought together doctors from different department such as physiotherapy, neurology, and rehabilitation, to deepen their expertise with Xeomin® across different therapeutic indications.

During the workshop, participants explored best practices in spasticity, cervical dystonia, blepharospasm and hemifacial spasm, combining theoretical discussions with ultrasound-guided, hands-on training for targeted BoNT-A administration.

A great opportunity for scientific exchange, collaboration, and skill enhancement in real clinical settings.

02/12/2025

From our Lunatus family to the UAE community – Happy 54th National Day!
Grateful for the opportunity to grow, innovate and serve patients in this inspiring country 🇦🇪

28/11/2025

Second Wave of Rethinking Antimuscarinics: Innovation, Efficacy, and Safety with Trospium Chloride,” a scientific session organized by Lunatus, convened more than 100 urologists for an expert-driven exploration of evolving strategies in overactive bladder (OAB) management and the clinical value of Spasmex.
The event served as a dynamic platform for sharing cutting-edge insights, real-world clinical experience, and forward-looking approaches aimed at elevating patient outcomes.
Two renowned leaders in urology headlined the session.�Prof. Andreas Wiedemann, Head of the Urology Department at the Protestant Hospital in Germany, contributed deep expertise shaped by his internationally recognized work in uro-geriatrics, lower urinary tract dysfunction, continence care, and research on anticholinergic burden.

Serving as Chair was Dr.Yahya Ghazwani, MD Head of Division of Urology at National Guard Health Affairs and King Abdulaziz Medical City, Chairman of the Urology Scientific Council, SCFHS, Associate Professor, KSAU-HS ( King Saud bin Abdulaziz University for Health Sciences ) Riyadh, Saudi Arabia.
Together, they delivered a compelling and authoritative discussion on the evolution of evidence-based antimuscarinic therapy and its pivotal role in optimizing outcomes for patients with overactive bladder.

25/11/2025

Rethinking Antimuscarinics: Innovation, Efficacy, and Safety with Trospium Chloride—a scientific session organized by Lunatus—brought together more than 100 experts for an expert-driven deep dive into evolving strategies for overactive bladder (OAB) management and the clinical role of Spasmex.
The event provided a rich platform for cutting-edge insights, real-world clinical experience, and forward-thinking approaches aimed at elevating patient care.
The session featured two distinguished leaders in the field of urology.
Prof. Andreas Wiedemann, Head of the Urology Department at the Protestant Hospital in Germany, shared expertise shaped by his internationally recognized work in uro-geriatrics, lower urinary tract disorders, continence management, and research on anticholinergic burden.
Chairperson Asst. Prof. Dr. Abdulghafour Al Halawani, Urologist at King Abdulaziz University, a forward-thinking innovator in urological care whose work focuses on Endourology and advancing the management of kidney stones and benign prostatic hyperplasia (BPH).
Together, they provided an authoritative platform for discussing the advancement of evidence-based antimuscarinic therapy, highlighting its role in optimizing outcomes in overactive bladder management.

21/11/2025

Lunatus participated at the 13th Emirates Orthopaedic Society Meeting and 1st Gulf Knee Course (EOS), which took place from 14–16 November 2025 at the Event Centre in Intercontinental Dubai Festival City, Dubai, UAE.
It was a great opportunity to connect with many Orthopedic Professionals from different countries, exchanging insights, and exploring new advancements in Musculoskeletal diseases.

20/11/2025

Lunatus was proud to take part in the Annual Global Management Meeting by LD Collins in Antalya — a gathering of partners from around the world to celebrate growth, share insights, and reinforce the clinical leadership of Cyclogest.

During the meeting, our team presented “From Challenge to Leadership”, showcasing Lunatus’s journey in building Cyclogest as the gold standard in fertility treatment, recurrent miscarriage prevention, and reducing the risk of preterm birth — driven by unwavering persistence and strong clinical evidence.

We are honored to have been recognized with the Best Performance Award, celebrating our 5-year CAGR growth in KSA and our continued commitment to excellence across the region.

Proud of our team. Grateful for the partnership. Motivated for what’s next.

17/11/2025

1 in 10 babies are born prematurely every year worldwide.
A powerful reminder that nothing matters more than the gift of life.

Preterm birth—defined as delivery before 37 weeks—is one of the leading causes of morbidity in children under five (WHO).

Cyclogest®️ plays a clinically proven role in reducing the risk of preterm birth, helping deliver little miracles every day.

Cyclogest provides bioidentical micronized progesterone targeted support to the placenta—Stimulating the secretion of essential nutrients, nurturing the embryo and relax the uterine contractions to ultimately contribute to the completion of the gestational term.

Honoring World Prematurity Day and the strength of every mother, baby, and healthcare professional behind these journeys. 💜👶🌎

07/11/2025

🤝 In collaboration with Al Ain Pharmacy Group, our Lunatus team delivered a two-wave pharmacy experience & training—spotlighting our consumer portfolio and its role in everyday health.
🧑💬 Elevating patient-centered care through effective counseling & product awareness.

05/11/2025

Proud to partner with Boots Pharmacy on a training session all about a holistic wellness approach 🌿
Through interactive discussions and case-based learning, participants picked up tools to better understand consumer needs and highlight the value of our healthcare solutions 🧩💬
Better support. Better care. Better outcomes—together. 🤝✨

Address

Dubai

Telephone

043994755

Website

http://www.lunatus.com/

Alerts

Be the first to know and let us send you an email when Lunatus Healthcare posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Lunatus Healthcare:

Shortcuts

Want your practice to be the top-listed Clinic in Dubai?